Skip to Main Content

Advertisement

Skip Nav Destination

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Blood (2017) 130 (16): 1857–1868.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement